Company Filing History:
Years Active: 2016
Title: Lázaro Gil González: Innovator in Vaccine Development
Introduction
Lázaro Gil González is a prominent inventor based in Mayabeque, Cuba. He is recognized for his significant contributions to the field of vaccine development, particularly in relation to the dengue virus. His innovative work has the potential to impact public health positively.
Latest Patents
Lázaro Gil González holds a patent for a dengue virus vaccine composition. This vaccine comprises at least one antigen based on the dengue virus (DV) capsid protein and the oligonucleotide identified as SEQ ID NO 1. The composition includes a fusion protein formed by the DV2 capsid and domain III of the envelope protein of the same serotype. This formulation has demonstrated higher levels of cellular immune response and protection in mice compared to previous formulations. The efficacy of these compositions has also been validated in non-human primates. The vaccine compositions can be monovalent, bivalent, or tetravalent and are designed to induce a functional immune response to the four viral serotypes.
Career Highlights
Throughout his career, Lázaro has worked with notable institutions such as the Centro de Ingeniería Genética y Biotecnología. His research and innovations have contributed significantly to advancements in biotechnology and vaccine development.
Collaborations
Lázaro has collaborated with Alienys Izquierdo Oliva, further enhancing the scope and impact of his research in the field.
Conclusion
Lázaro Gil González is a key figure in the development of innovative vaccine solutions for dengue virus, showcasing the importance of research and collaboration in addressing global health challenges. His work continues to pave the way for future advancements in vaccine technology.